Trial intelligence / Profile preview

Intravenous midazolam before spinal anesthesia for cesarean section

IRCT20220501054718N1Phase 3Completed

Sponsor
Gonabad University of Medical Sciences
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of midazolam (2 arms), sponsored by Gonabad University of Medical Sciences. Primary endpoints: Maternal hemodynamic factors, Neonatal Apgar score at 1 minute and 1 more. Started Aug 2022; status: completed.

02

Drugs

midazolam

Beyond the preview

Go deeper on IRCT20220501054718N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220501054718N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call